Stocks & Investing
Fri, August 2, 2024
[ Fri, Aug 02nd 2024
] - WOPRAI
Mon, June 24, 2024
[ Mon, Jun 24th 2024
] - WOPRAI
Mon, June 17, 2024
[ Mon, Jun 17th 2024
] - WOPRAI
Tue, March 26, 2024
[ Tue, Mar 26th 2024
] - WOPRAI
Fri, January 26, 2024
[ Fri, Jan 26th 2024
] - WOPRAI
Thu, January 18, 2024
[ Thu, Jan 18th 2024
] - WOPRAI
Thu, December 21, 2023
[ Thu, Dec 21st 2023
] - WOPRAI
Fri, October 13, 2023
[ Fri, Oct 13th 2023
] - WOPRAI
Thu, August 31, 2023
[ Thu, Aug 31st 2023
] - WOPRAI
Mon, July 24, 2023
[ Mon, Jul 24th 2023
] - WOPRAI
Mon, April 3, 2023
[ Mon, Apr 03rd 2023
] - WOPRAI
Thu, February 23, 2023
[ Thu, Feb 23rd 2023
] - WOPRAI
Fri, August 26, 2022
[ Fri, Aug 26th 2022
] - WOPRAI
Mon, July 25, 2022
[ Mon, Jul 25th 2022
] - WOPRAI
Fri, May 27, 2022
[ Fri, May 27th 2022
] - WOPRAI
Allison Bratzel Maintained (TVTX) at Hold with Increased Target to $12 on, Aug 2nd, 2024
Allison Bratzel of Piper Sandler, Maintained "Travere Therapeutics, Inc." (TVTX) at Hold with Increased Target from $11 to $12 on, Aug 2nd, 2024.
Allison has made no other calls on TVTX in the last 4 months.
There are 2 other peers that have a rating on TVTX. Out of the 2 peers that are also analyzing TVTX, 0 agree with Allison's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Allison
- Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $19 on, Tuesday, May 7th, 2024
- Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $18 on, Tuesday, May 7th, 2024
